二甲双胍在患有慢性肾脏病的2型糖尿病患者中的应用：是时候放宽给药建议了吗？ - Suppr

Suppr

超能文献

Metformin Use in Type 2 Diabetes Mellitus With CKD: Is It Time to Liberalize Dosing Recommendations?

作者信息

Stanton Robert C

机构信息

Joslin Diabetes Center, Harvard Medical School, Boston, MA.

出版信息

Am J Kidney Dis. 2015 Aug;66(2):193-5. doi: 10.1053/j.ajkd.2015.04.001. Epub 2015 May 8.

DOI:10.1053/j.ajkd.2015.04.001

PMID:25960301

Abstract

摘要

相似文献

Metformin Use in Type 2 Diabetes Mellitus With CKD: Is It Time to Liberalize Dosing Recommendations?

Am J Kidney Dis. 2015 Aug;66(2):193-5. doi: 10.1053/j.ajkd.2015.04.001. Epub 2015 May 8.

Restricting Metformin in CKD: Continued Caution Warranted.

Am J Kidney Dis. 2015 Dec;66(6):1101-2. doi: 10.1053/j.ajkd.2015.07.039.

In Reply to 'Restricting Metformin in CKD: Continued Caution Warranted'.

Am J Kidney Dis. 2015 Dec;66(6):1102. doi: 10.1053/j.ajkd.2015.09.012.

Metformin OK in CKD?

Drug Ther Bull. 2014 Apr;52(4):37. doi: 10.1136/dtb.2014.4.0244. Epub 2014 Apr 3.

Metformin should not be contraindicated in patients with type 2 diabetes and mild to moderate renal impairment.

Evid Based Med. 2015 Jun;20(3):115. doi: 10.1136/ebmed-2015-110184. Epub 2015 Mar 31.

[Chronic kidney diseases, metformin and lactic acidosis].

Vnitr Lek. 2016 Apr;62(4):299-303.

Metformin: time to review its role and safety in chronic kidney disease.

Med J Aust. 2019 Jul;211(1):37-42. doi: 10.5694/mja2.50239. Epub 2019 Jun 12.

Refining metformin prescribing in New Zealand.

N Z Med J. 2017 Mar 24;130(1452):49-53.

Metformin use in decompensated heart failure.

Cardiol Rev. 2008 Sep-Oct;16(5):269-72. doi: 10.1097/CRD.0b013e3181846c53.

Metformin therapy in patients with chronic kidney disease.

Diabetes Obes Metab. 2012 Oct;14(10):963-5. doi: 10.1111/j.1463-1326.2012.01617.x. Epub 2012 May 27.

引用本文的文献

Further clarifying the relationship between metformin, acute kidney injury and lactic acidosis.

Nat Rev Nephrol. 2017 Dec 13;14(1):70. doi: 10.1038/nrneph.2017.174.

Risks of Metformin in Type 2 Diabetes and Chronic Kidney Disease: Lessons Learned from Taiwanese Data.

Nephron. 2017;135(2):147-153. doi: 10.1159/000450862. Epub 2016 Oct 20.

Metformin associated lactic acidosis (MALA): clinical profiling and management.

J Nephrol. 2016 Dec;29(6):783-789. doi: 10.1007/s40620-016-0267-8. Epub 2016 Jan 22.

Restricting Metformin in CKD: Continued Caution Warranted.

Am J Kidney Dis. 2015 Dec;66(6):1101-2. doi: 10.1053/j.ajkd.2015.07.039.

Therapy: Risk of metformin use in patients with T2DM and advanced CKD.

Nat Rev Endocrinol. 2015 Dec;11(12):697-9. doi: 10.1038/nrendo.2015.132. Epub 2015 Aug 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Metformin Use in Type 2 Diabetes Mellitus With CKD: Is It Time to Liberalize Dosing Recommendations?

Am J Kidney Dis. 2015 Aug;66(2):193-5. doi: 10.1053/j.ajkd.2015.04.001. Epub 2015 May 8.

Restricting Metformin in CKD: Continued Caution Warranted.

Am J Kidney Dis. 2015 Dec;66(6):1101-2. doi: 10.1053/j.ajkd.2015.07.039.

In Reply to 'Restricting Metformin in CKD: Continued Caution Warranted'.

Am J Kidney Dis. 2015 Dec;66(6):1102. doi: 10.1053/j.ajkd.2015.09.012.

Metformin OK in CKD?

Drug Ther Bull. 2014 Apr;52(4):37. doi: 10.1136/dtb.2014.4.0244. Epub 2014 Apr 3.

Metformin should not be contraindicated in patients with type 2 diabetes and mild to moderate renal impairment.

Evid Based Med. 2015 Jun;20(3):115. doi: 10.1136/ebmed-2015-110184. Epub 2015 Mar 31.

[Chronic kidney diseases, metformin and lactic acidosis].

Vnitr Lek. 2016 Apr;62(4):299-303.

Metformin: time to review its role and safety in chronic kidney disease.

Med J Aust. 2019 Jul;211(1):37-42. doi: 10.5694/mja2.50239. Epub 2019 Jun 12.

Refining metformin prescribing in New Zealand.

N Z Med J. 2017 Mar 24;130(1452):49-53.

Metformin use in decompensated heart failure.

Cardiol Rev. 2008 Sep-Oct;16(5):269-72. doi: 10.1097/CRD.0b013e3181846c53.

Metformin therapy in patients with chronic kidney disease.

Diabetes Obes Metab. 2012 Oct;14(10):963-5. doi: 10.1111/j.1463-1326.2012.01617.x. Epub 2012 May 27.

引用本文的文献

Further clarifying the relationship between metformin, acute kidney injury and lactic acidosis.

Nat Rev Nephrol. 2017 Dec 13;14(1):70. doi: 10.1038/nrneph.2017.174.

Risks of Metformin in Type 2 Diabetes and Chronic Kidney Disease: Lessons Learned from Taiwanese Data.

Nephron. 2017;135(2):147-153. doi: 10.1159/000450862. Epub 2016 Oct 20.

Metformin associated lactic acidosis (MALA): clinical profiling and management.

J Nephrol. 2016 Dec;29(6):783-789. doi: 10.1007/s40620-016-0267-8. Epub 2016 Jan 22.

Restricting Metformin in CKD: Continued Caution Warranted.

Am J Kidney Dis. 2015 Dec;66(6):1101-2. doi: 10.1053/j.ajkd.2015.07.039.

Therapy: Risk of metformin use in patients with T2DM and advanced CKD.

Nat Rev Endocrinol. 2015 Dec;11(12):697-9. doi: 10.1038/nrendo.2015.132. Epub 2015 Aug 18.